KBC Group’s Hydrogenics Corp HYGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-43,703
Closed -$293K 1379
2017
Q1
$293K Buy
43,703
+2,969
+7% +$17.5K ﹤0.01% 1138
2016
Q4
$179K Hold
40,734
﹤0.01% 1211
2016
Q3
$267K Buy
40,734
+3,205
+9% +$20.1K ﹤0.01% 1100
2016
Q2
$259K Hold
37,529
﹤0.01% 1040
2016
Q1
$307K Buy
37,529
+7,721
+26% +$60.6K 0.01% 955
2015
Q4
$261K Sell
29,808
-49,445
-62% -$481K ﹤0.01% 934
2015
Q3
$639K Buy
79,253
+12,668
+19% +$111K 0.01% 711
2015
Q2
$677K Buy
66,585
+20,131
+43% +$225K 0.01% 812
2015
Q1
$526K Buy
46,454
+9,056
+24% +$125K 0.01% 890
2014
Q4
$497K Buy
37,398
+32,002
+593% +$479K 0.01% 968
2014
Q3
$91K Buy
+5,396
New +$110K ﹤0.01% 1156

Other funds holding HYGS

KBC Group's HYGS Position: Q2 2017 in Review

KBC Group sold out of Hydrogenics Corp (HYGS) in Q2 2017, closing a stake of 43,703 shares — an estimated $293K sold.

KBC Group first reported a position in HYGS in Q3 2014 and held it in 11 quarters. The position peaked at $677K in Q2 2015. 38 funds tracked by Wall St. Rank hold HYGS as of Q2 2017.

  • KBC Group reported no remaining Hydrogenics Corp position as of Q2 2017 after selling out during the quarter.
  • KBC Group sold 43,703 Hydrogenics Corp shares in Q2 2017, an estimated $293K.
  • KBC Group first reported a position in Hydrogenics Corp in Q3 2014 and held it in 11 quarters.
  • KBC Group's Hydrogenics Corp position peaked at $677K in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Hydrogenics Corp as of Q2 2017.

Based on KBC Group's 13F filing for Q2 2017, filed 4 Aug 2017.